Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66


Polyclonal antibodies to xenogeneic endothelial cells induce apoptosis and block support of tumor growth in mice.

Scappaticci FA, Contreras A, Boswell CA, Lewis JS, Nolan G.

Vaccine. 2003 Jun 2;21(19-20):2667-77.


Induction of anti-tumor immunity in mice using a syngeneic endothelial cell vaccine.

Scappaticci FA, Nolan GP.

Anticancer Res. 2003 Mar-Apr;23(2B):1165-72.


Immunotherapy of tumors with protein vaccine based on chicken homologous Tie-2.

Luo Y, Wen YJ, Ding ZY, Fu CH, Wu Y, Liu JY, Li Q, He QM, Zhao X, Jiang Y, Li J, Deng HX, Kang B, Mao YQ, Wei YQ.

Clin Cancer Res. 2006 Mar 15;12(6):1813-9.


Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity.

Chen XY, Zhang W, Zhang W, Wu S, Bi F, Su YJ, Tan XY, Liu JN, Zhang J.

Clin Cancer Res. 2006 Oct 1;12(19):5834-40.


Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.

Huh JI, Calvo A, Stafford J, Cheung M, Kumar R, Philp D, Kleinman HK, Green JE.

Oncogene. 2005 Jan 27;24(5):790-800. Erratum in: Oncogene. 2005 Jun 9;24(25):4164.


CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.

Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.

Cancer Res. 2003 Sep 15;63(18):5978-91. Erratum in: Cancer Res. 2003 Nov 1;63(21):7543.


Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen.

Bouquet C, Lamandé N, Brand M, Gasc JM, Jullienne B, Faure G, Griscelli F, Opolon P, Connault E, Perricaudet M, Corvol P.

Mol Ther. 2006 Aug;14(2):175-82.


Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.

Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY.

Life Sci. 2006 Nov 17;79(25):2370-81.


Inhibition of B16 melanoma growth and metastasis in C57BL mice by vaccination with a syngeneic endothelial cell line.

Yoshiura K, Nishishita T, Nakaoka T, Yamashita N, Yamashita N.

J Exp Clin Cancer Res. 2009 Jan 31;28:13. doi: 10.1186/1756-9966-28-13.


Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin.

Trochon-Joseph V, Martel-Renoir D, Mir LM, Thomaïdis A, Opolon P, Connault E, Li H, Grenet C, Fauvel-Lafève F, Soria J, Legrand C, Soria C, Perricaudet M, Lu H.

Cancer Res. 2004 Mar 15;64(6):2062-9.


Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.

Kaliski A, Maggiorella L, Cengel KA, Mathe D, Rouffiac V, Opolon P, Lassau N, Bourhis J, Deutsch E.

Mol Cancer Ther. 2005 Nov;4(11):1717-28.


Antitumor activity of tributyrin in murine melanoma model.

Giermasz A, Nowis D, Jalili A, Basak G, Marczak M, Makowski M, Czajka A, Młynarczuk I, Hoser G, Stok osa T, Lewandowski S, Jakóbisiak M.

Cancer Lett. 2001 Mar 26;164(2):143-8.


Inhibition of tumor angiogenesis in vivo by a monoclonal antibody targeted to domain 5 of high molecular weight kininogen.

Song JS, Sainz IM, Cosenza SC, Isordia-Salas I, Bior A, Bradford HN, Guo YL, Pixley RA, Reddy EP, Colman RW.

Blood. 2004 Oct 1;104(7):2065-72.


[The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination].

Luo F, Mao YQ, Kan B, He QM, Jiang Y, Peng F, Yang L, Tian L.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 Nov;35(6):757-60. Chinese.


Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice.

Banciu M, Schiffelers RM, Fens MH, Metselaar JM, Storm G.

J Control Release. 2006 Jun 12;113(1):1-8.


Effects of a novel immunomodulating agent, FTY720, on tumor growth and angiogenesis in hepatocellular carcinoma.

Ho JW, Man K, Sun CK, Lee TK, Poon RT, Fan ST.

Mol Cancer Ther. 2005 Sep;4(9):1430-8.


Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.

Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.

Chin Med J (Engl). 2008 Nov 20;121(22):2324-30.

Items per page

Supplemental Content

Support Center